Design Crafted with Care for a Sensitive Audience
Working thru deClarity bioCommunications in Redwood City, Ghostdog designed websites for two Medivation drug trials for prostate cancer.  The first, Affirm, was designed with a sensitivity to the worldwide target audience, adding warmth, while maintaining medical trust.  Doctors were a secondary audience.   

The website for PreVail, the second trial, was designed with a similar yet distinctive look.  Second level pages, while part of a templated system for consisteny, each had unique elements to encourage readership.  Because of the trial qualifications, clarity of content presentation helped minimize questions.  Both trials were filled and the websites discontinued.